 A STUDY EVALUATING THE SAFETY OF TOCILIZUMAB IN ADDITION TO STANDARD OF CARE PREMEDICATION GIVEN BEFORE OBINUTUZUMAB CHLORAMBUCIL IN PARTICIPANTS WITH UNTREATED B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA B-CLL AND COMORBIDITIES: 